(R)-carnitine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The results of the chi-square test revealed that the 28-day mortality rate was lower in the intervention group in comparison to the control group (7 persons (23.33%) vs. 15 persons (50.00%), p-value: 0.032).”
Quoted verbatim from The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial.. - Study
- RCT
- Duration
- 7 days
- Dose
- L-carnitine 3 g/day (1 g three times daily) for 7 days
- Population
- Critically ill adult patients with sepsis in a general ICU, enterally fed, receiving standard treatment in both arms; 28-day follow-up by telephone
The effects of L-carnitine supplementation on inflammation, oxidative stress, and clinical outcomes in critically Ill patients with sepsis: a randomized, double-blind, controlled trial.2024PMID:38444016Permalink
Keep reading
- Everything the graph holds on (R)-carnitine
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PEAKK7253PE950GAQE3TRJ